Introduction: This study evaluated the consumption of major classes of antibiotics, the colonization of the oropharynx of patients on mechanical ventilation, and the risk of ventilatorassociated pneumonia (VAP) caused by Staphylococcus aureus in an intensive care unit for adults. Methods: A case-control study was carried out using colonized patients (cases) by oxacillinresistant S. aureus (ORSA) and (controls) oxacillin-sensitive S. aureus (OSSA) from May 2009 to August 2010. The occurrence of VAP by S. aureus was also evaluated in the same period. Antibiotic consumption was expressed as the number of defined daily doses (DDD)/1,000 patient-days for glycopeptides, carbapenems, and extended-spectrum cephalosporins. Results: Three hundred forty-six (56.1%) patients underwent mechanical ventilation with a frequency of oropharyngeal colonization of 36.4%, corresponding to 63.5% for ORSA and 36.5% for OSSA. The risk of illness for this organism was significant (p≤0.05), regardless of whether colonization/infection was by ORSA or OSSA. The consumption of antibiotics was high, mainly for broad-spectrum cephalosporins (551.26 DDDs/1,000 patient-days). The high density of use of glycopeptides (269.56 DDDs/1,000 patient-days) was related to colonization by ORSA (Pearson r=0.57/p=0.02). Additionally, age >60 years, previous antibiotic therapy, and previous use of carbapenems were statistically significant by multivariate analysis. Conclusions: There was a significant relationship between the colonization of the oropharyngeal mucosa and the risk of VAP by both phenotypes. The use of glycopeptides was related to colonization by ORSA.
INTRODUCTION

Article/Artigo
Nosocomial infections pose a significant threat to patients worldwide, and antibiotic-resistant bacteria are related to a greater impact on morbidity/ mortality and the costs of such infections [1] [2] [3] . Ventilator-associated pneumonia (VAP) is the most frequent infection acquired in the intensive care unit (ICU), occurring in 9% to 24% of patients intubated for longer than 48h 4, 5 . It is associated with increased morbidity, prolonged hospitalization, and increased healthcare costs 58 .
Each antibiotic prescription has an environmental and ecological consequence 9, 10 . Many case-control studies demonstrate prior antibiotic exposure, particularly with cephalosporins and fluoroquinolones, as a risk factor for both oxacillin-resistant Staphylococcus aureus (ORSA) colonization and infection 2, 10 . Antibiotics such as fluoroquinolones and cephalosporins are well known to increase the expression of fibronectin adhesions, facilitating adherence and ability to colonize, and many other virulence factors such as toxins that might cause colonization and develop into infection [10] [11] [12] .
Increased numbers of ORSA were demonstrated in the noses of carriers receiving fluoroquinolones or β-lactams compared with controls 13 . Presumably this is due to a competitive advantage achieved by antibiotic administration, ablating the normal protective commensal flora, including oxacillinsensitive S. aureus (OSSA), allowing multiplication of the ORSA with increased potential for contaminating the environment 10 .
The aim of this study was to evaluate the consumption of major classes of antibiotics, the colonization of the oropharynx of patients on mechanical ventilation (MV), and the risk of VAP caused by S. aureus susceptible or resistant to oxacillin, as well as other risk factors in patients in an adult mixed ICU from a Brazilian university hospital. 
Setting
The Uberlândia Federal University-Hospital Clinic (UFU-HC) is a teaching hospital with 500 beds and a clinical-surgical ICU for adults with 15 beds.
Study design
A case-control study was carried out using colonized patients by ORSA (case) and OSSA (control) from May 2009 to August 2010, when 617 patients were admitted. The cultures of oropharyngeal secretions were taken at baseline (< 24h in the ICU) and every 2 days until the confirmation of colonization or discharge. In the same period the occurrence of VAPs by S. aureus was also evaluated.
The patients with VAP were under MV for a period ≥48h after being admitted to the ICU, with new and/or progressive radiological infiltrate and experiencing at least two of the following conditions: purulent sputum, temperature higher than 38.5 o C or lower than 35 o C, and leukocyte count higher than 10,000/µL with deviation to the left or lower than 3,000/µL; and positive quantitative culture of the endotracheal aspirate (count ≥10 6 CFU/ml) [14] [15] [16] . Antibiotic consumption was expressed as the number of defined daily doses (DDD)/1,000 patient-days for the following classes: glycopeptides (vancomycin and teicoplanin), carbapenems (imipenem, meropenem, and ertapenem), and extended-spectrum cephalosporins (ceftriaxone and cefepime).
Additionally, the following patient data were collected: age, gender, invasive procedures, admission diagnosis, previous use of antibiotics and corticoids, hospitalization, and MV times.
Microbiological techniques
The collection of clinical specimen obtained from the oropharynx was made with a swab, and the specimen was transported in sterile tube with 1ml of trypticase soy broth supplemented with 6.5% NaCl. Endotracheal aspirate was collected by probe n 12 early in the morning by the health professionals (physiotherapists and nurses) in charge of the procedure, and was transported in a sterile tube to the Microbiology Laboratory of UFU. Oropharynx and endotracheal aspirate samples were cultivated in salty mannitol agar (Biobrás, Brazil) by qualitative and quantitative techniques, respectively. The S. aureus isolates were identified by mannitol fermentation, Gram stain, and catalase, free coagulase, and bond coagulase tests. Resistance to oxacillin was detected by means of a screening test in salty mannitol agar (Biobrás, Brazil) incorporated with 6µg/ml of oxacillin and 4.5% of NaCl.
Statistical analysis
Univariate comparisons were carried out using the Qui-Square (X 2 ) and Fisher's exact tests. Multivariate analysis was carried out by simple or multiple logistic regression when appropriate, and the values were included when significance was <0.25 in univariate analysis or in case of clinical relevance. Pearson's correlation coefficient was used to determine the relationship between antibiotic consumption and trends in resistance. The results were considered statistically significant at a level of 5%. The epidemiological data were analyzed through the programs Epi-Info version 5. 
Ethical considerations
The Ethics Committee for Human Research of UFU approved the project.
From May 2009 to August 2010 a total of 617 adult patients were admitted to the adult ICU of the UFU-HC. Three hundred forty-six (56.1%) patients who were submitted to MV. All these patients were surveyed, and 126 (36.4%) were colonized in the oropharynx with S. aureus; 63.5% were ORSA and 36.5% were OSSA, corresponding to 10.97 ± 6.67 and 6.26 ± 4.49 colonizations/1,000 patient-days for these microorganisms, respectively. Among the 320 (51.9%) patients submitted to MV for longer than 48h, VAP was diagnosed in 81 (25.3%) patients, the main agents being represented by Pseudomonas aeruginosa and Acinetobacter baumannii.
Although high frequencies of colonization of the mucous membranes of the oropharynx by S. aureus (126/346; 36.4%), ORSA (80/346; 23.1%), and OSSA (46/346; 13.3%) were found, the participation of these microorganisms in VAPs was low at 11 (13.6%) of 81, 4 (4.9%)of 81, and 7 (8.6%) of 81, respectively. The risk of illness in patients colonized in oropharynx was 7 (5.5%) of 126, 4 (5%) of 80, and 3 (6.5%)of 46 for S. aureus, ORSA, and OSSA, respectively. Four patients had episodes of VAP (4 OSSA) without previous colonization by this microorganism. The risk of pneumonia was significant (p ≤ 0.05) by univariate analysis, regardless of whether colonization/infection was by ORSA or OSSA (Table 1) .
Confidence interval
Odds ratio The average time to colonization was slightly longer for ORSA (5.8 days) than for OSSA (5.0 days) ( Table 2) Staphylococcus aureus was colonizing the oropharynx in 36.4% of patients undergoing MV at the ICU of the UFU-HC, with 63.5% corresponding to ORSA and 36.5% to OSSA. The colonization of mucous membranes of the upper respiratory tract with potentially pathogenic microorganisms is particularly common in critically ill patients, especially those with decreased level of consciousness, which occurs frequently in ICUs 20 . For these patients, especially in the ICU, the normal microbiota undergoes drastic changes due to the use of antibiotics 21, 22 and the action of proteases that decrease immunoglobulin and fibronectin present in the mucosa, preventing the adherence of microorganisms of the normal microbiota, favoring Gram-negative bacilli and S. aureus 22, 23 . Oropharyngeal and tracheal colonization plays a central role in the pathogenesis of VAP 16, 24 . In studies of intensive-care patients, ORSA colonizes the throat more frequently than it does either the nose or the groin/axilla [25] [26] [27] [28] , and nasal colonization with ORSA is a poor predictor for the subsequent occurrence of ORSA lower respiratory tract infections that require antimicrobial treatment 29 . On the other hand, there is less information on the etiopathogenesis for the development of VAP by ORSA. DNA genomic analysis demonstrated that an identical strain was isolated from oropharyngeal or gastric samples and bronchial samples in all but three cases of pneumonia, due to S. aureus 30, 31 . In our study 5.5% of patients colonized by S. aureus developed VAP as opposed to just 1.8% of patients not colonized (p > 0.05), and among individuals colonized by phenotypes ORSA and OSSA, 5% and 6.5% developed VAP, respectively, as opposed to just 0% and 1.3% (p = 0.003/p = 0.05) of patients not colonized for these phenotypes, respectively. However, S. aureus was isolated in only 13.6% of episodes of VAP, the main agents being represented by Pseudomonas aeruginosa and Acinetobacter baumannii.
In a recent multi-centric study including 1,290 patients infected in the ICUs of hospitals in South and Central America, accounting for 60.3% of inpatients, pneumonia accounted for most (66%), predominated (70.9%) by Gram-negative bacteria, while ORSA accounted for just 10.4% 32 . Recent data from the European Antimicrobial Resistance Surveillance Network show that six countries reported decreasing trends in the proportion of ORSA among S. aureus isolates from invasive infections for the period 2006-2009. This is likely due to sustained efforts to contain the spread of ORSA in hospitals and other healthcare facilities 33 . In three ICUs in France the acquisition of ORSA was reduced from 7% to 3% through multiple interventions, including active surveillance cultures, contact precautions, and the use of alcohol hand hub 34, 35 . In other regions/ countries, however, S. aureus, particularly ORSA, remains endemic in larger hospitals as a major cause of bloodstream infections and pneumonia 32, 36, 37 . In this investigation, their participation in VAPs was small compared with that of Gram-negative bacilli, although the rates of oropharyngeal colonization are significant, representing a potential risk for developing this infection.
With a hospital stay of 5 days or longer, the patient is at greater risk of acquiring more resistant pathogens, and empirical treatment with broad-spectrum antimicrobial agents should be prescribed 38 . In our
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FINANCIAL SUPPORT REFERENCES study, the mean time to colonization was 5.8 for ORSA and 5.0 for OSSA, and oropharyngeal colonization occurred in 93.7% of patients with ORSA and 65.2% with OSSA, from the first week in the unit. Antibiotic pressure has been described as a risk factor for the acquisition of ORSA [39] [40] [41] , and the use of antibiotics during and prior to hospitalization in ICU has been shown to increase the number of ORSA infections [41] [42] [43] [44] . Our results show an increased risk of acquiring ORSA if antibiotics are administered prior and during hospitalization in ICU (p ≤ 0.05). A meta-analysis has shown that subjects who have been exposed to antibiotic therapy have an almost 2-fold chance of acquiring ORSA as opposed to non-exposed subjects. This risk is almost three times greater after the use of fluoroquinolones and glycopeptides beyond the cephalosporins 2 . Aldeyab et al. 45 built a multivariate ARIMA model (time series analysis) to relate ORSA incidence with antibiotic usage. Retrospective analysis of a 5-year data set showed that temporal variation in ORSA incidence followed temporal variations in the use of fluoroquinolones, broad-spectrum cephalosporins, macrolides, and amoxicillin/clavulanic acid. In our study the use of antibiotics was high compared with that in American and European studies 46, 47 , mainly for broad-spectrum cephalosporins, with higher recovery of ORSA; however, the high density of use of glycopeptides in the ICU was significantly related to the acquisition of the multidrug-resistant phenotype by patients, as well as previous use of carbapenems. In addition, patients who had prior use of fluoroquinolones were two times more likely to acquire ORSA (p > 0.05). The need to improve antibiotic prescribing in hospitals worldwide is urgent. Guidelines from the Society of Hospital Epidemiologists of America and the Infectious Diseases Society of America strongly support the wide diffusion of antibiotic stewardship programs in healthcare settings 48, 49 . Changing hospital antibiotic use is a challenge of formidable complexity. Many determinants (cultural, contextual, and behavioral) affect antibiotic use in hospitals. The great diversity of the determinants dictates that measures or strategies to improve antibiotic use need to be equally diverse 50 .
Age >60 years was considered an independent risk factor for the acquisition of ORSA (p = 0.04), as were previous antibiotic therapy (p = 0.04) and previous use of carbapenems (p = 0.03). These risk factors correspond to what is reported in the literature, which includes underlying diseases, prior hospitalization, duration of hospitalization, admission to ICU, central venous catheterization, enteral feeding, nursing staff workload, and poor compliance with hand hygiene 2,39, 51, 52 . There was a significant relationship between colonization of the oropharyngeal mucosa and the risk of VAP by ORSA or OSSA. The consumption of antibiotics was high mainly for broad-spectrum cephalosporins, and the high density of use of glycopeptides was associated with colonization by ORSA. Age >60 years, previous antibiotic therapy, and previous use of carbapenems were considered independent risk factors for acquisition of ORSA. However, despite a high rate of colonization by this microorganism, its involvement in the etiology of VAPs was small, overcome by Gram-negative bacilli.
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